U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 799

1.
Neurofilament heavy chain in secondary progressive multiple sclerosis
Floriana De Angelis, Francesca Ammoscato, Richard A Parker, Domenico Plantone, Anisha Doshi, Nevin A John, Thomas Williams, Jonathan Stutters, Dave MacManus, Klaus Schmierer, Frederik Barkhof, Christopher J Weir, Gavin Giovannoni, Jeremy Chataway, Sharmilee Gnanapavan
Mult Scler. 2025 Mar; 31(3): 303–313. Published online 2025 Jan 22. doi: 10.1177/13524585241311212
PMCID:
PMC11907725
ArticlePDF–1.1M
2.
Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis
Ronja Christensen, Amy Jolly, Charmaine Yam, Marios C Yiannakas, Ahmed T Toosy, Marco Pitteri, Anna He, Riccardo Nistri, Suraya Mohamud, Eirini Samdanidou, Alan J Thompson, Olga Ciccarelli
Mult Scler. 2025 Feb; 31(2): 218–230. Published online 2024 Dec 20. doi: 10.1177/13524585241304356
PMCID:
PMC11789427
ArticlePDF–1.0M
3.
Imaging Outcomes for Phase 2 Trials Targeting Compartmentalized Inflammation
María I. Gaitán, Rocio V. Marquez, Jeremias Ayerbe, Daniel S Reich
Mult Scler. Author manuscript; available in PMC 2024 Dec 12.
Published in final edited form as: Mult Scler. 2024 Dec; 30(5 Suppl): 48–60. doi: 10.1177/13524585241301303
PMCID:
PMC11637223
ArticlePDF–790K
4.
Vaccination as a risk factor for pediatric multiple sclerosis: Insights from a retrospective case–control study
Sonia Darvishi, Ewan Donnachie, Christiane Gasperi, Alexander Hapfelmeier, Bernhard Hemmer
Mult Scler. 2024 Dec; 30(14): 1825–1829. Published online 2024 Nov 14. doi: 10.1177/13524585241297003
PMCID:
PMC11616212
ArticlePDF–803K
5.
Choroid plexus as a mediator of CNS inflammation in multiple sclerosis
Alexandra Hochstetler, Maria K. Lehtinen
Mult Scler. Author manuscript; available in PMC 2024 Dec 12.
Published in final edited form as: Mult Scler. 2024 Dec; 30(5 Suppl): 19–23. Published online 2024 Nov 6. doi: 10.1177/13524585241292974
PMCID:
PMC11634642
ArticlePDF–362K
6.
Exploring the relationship between polycystic ovarian syndrome, testosterone, and multiple sclerosis in women: A nationwide cohort study and genome-wide cross-trait analysis
Yuan Jiang, Carolyn E Cesta, Qianwen Liu, Elaine Kingwell, Pernilla Stridh, Klementy Shchetynsky, Tomas Olsson, Ingrid Kockum, Elisabet Stener-Victorin, Xia Jiang, Ali Manouchehrinia
Mult Scler. 2024 Dec; 30(14): 1765–1774. Published online 2024 Nov 6. doi: 10.1177/13524585241292802
PMCID:
PMC11616213
ArticlePDF–2.4M
7.
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients
Alyssa A Toorop, Mark HJ Wessels, Lynn Boonkamp, Liza MY Gelissen, E Hoitsma, Esther MPE Zeinstra, Luuk C van Rooij, Caspar EP van Munster, Anke Vennegoor, Jop P Mostert, Beatrijs HA Wokke, Nynke F Kalkers, Erwin LJ Hoogervorst, Jeroen JJ van Eijk, Christiaan M Roosendaal, Jolijn J Kragt, Marijke Eurelings, Jessie van Genugten, Jessica Nielsen, LGF Sinnige, Mark E Kloosterziel, Edo PJ Arnoldus, Gert W van Dijk, Willem H Bouvy, Eva MM Strijbis, Bob W van Oosten, Brigit A de Jong, Bernard MJ Uitdehaag, Theo Rispens, Joep Killestein, Zoé LE van Kempen, Charlotte E Teunissen
Mult Scler. 2024 Nov; 30(13): 1683–1688. Published online 2024 Nov 4. doi: 10.1177/13524585241293940
PMCID:
PMC11568651
ArticlePDF–876K
8.
Physical and psychological aspects of multiple sclerosis: Revisiting the Multiple Sclerosis Impact Scale (MSIS-29)
Carolyn A Young, David J Rog, Basil Sharrack, Radu Tanasescu, Seema Kalra, Suresh K Chhetri, Lisa Wilde, Roger J Mills, Alan Tennant
Mult Scler. 2024 Nov; 30(13): 1630–1641. Published online 2024 Oct 30. doi: 10.1177/13524585241288393
PMCID:
PMC11568641
ArticlePDF–819K
9.
Phenotyping in vivo chronic inflammation in multiple sclerosis by combined 11C-PBR28 MR-PET and 7T susceptibility-weighted imaging
Constantina A Treaba, Elena Herranz, Valeria T Barletta, Ambica Mehndiratta, Jacob A Sloane, Tobias Granberg, Alessandro Miscioscia, Roberto Bomprezzi, Marco L Loggia, Caterina Mainero
Mult Scler. Author manuscript; available in PMC 2025 Jan 19.
Published in final edited form as: Mult Scler. 2024 Dec; 30(14): 1755–1764. Published online 2024 Oct 22. doi: 10.1177/13524585241284157
PMCID:
PMC11742271
ArticlePDF–786K
10.
Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic
Zoë YGJ van Lierop, Mark HJ Wessels, Womei ML Lekranty, Bastiaan Moraal, Sam N Hof, Laura Hogenboom, Brigit A de Jong, Nandi Meijs, Liselore A Mensing, Bob W van Oosten, Nik Sol, Zoé LE van Kempen, Lisa Vermunt, Myrthe J Willems, Eva MM Strijbis, Bernard MJ Uitdehaag, Joep Killestein, Charlotte E Teunissen
Mult Scler. 2024 Nov; 30(13): 1620–1629. Published online 2024 Oct 17. doi: 10.1177/13524585241277044
PMCID:
PMC11568682
ArticlePDF–1.9M
11.
Integrating large language models in care, research, and education in multiple sclerosis management
Hernan Inojosa, Isabel Voigt, Judith Wenk, Dyke Ferber, Isabella Wiest, Dario Antweiler, Eva Weicken, Stephen Gilbert, Jakob Nikolas Kather, Katja Akgün, Tjalf Ziemssen
Mult Scler. 2024 Oct; 30(11-12): 1392–1401. Published online 2024 Sep 23. doi: 10.1177/13524585241277376
PMCID:
PMC11514324
ArticlePDF–701K
12.
The relationship between ethnicity and multiple sclerosis characteristics in the United Kingdom: A UK MS Register study
Benjamin M Jacobs, Luisa Schalk, Emily Tregaskis-Daniels, Pooja Tank, Sadid Hoque, Michelle Peter, Katherine Tuite-Dalton, James Witts, UK MS Register Study Group, Riley Bove, Ruth Dobson
Mult Scler. 2024 Oct; 30(11-12): 1544–1555. Published online 2024 Sep 20. doi: 10.1177/13524585241277018
PMCID:
PMC11520257
ArticlePDF–2.0M
13.
Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS
Marcus W. Koch, Carlos Camara-Lemarroy, Eva Strijbis, Jop Mostert, Victoria M. Leavitt, Pavle Repovic, James D. Bowen, Jacynthe Comtois, Bernard Uitdehaag, Gary Cutter
Mult Scler. 2024 Dec; 30(5 Suppl): 41–47. Published online 2024 Sep 8. doi: 10.1177/13524585241274620
PMCID:
PMC11633076
ArticlePDF–870K
14.
Mobility trajectories in multiple sclerosis: A comparative study of timed 25-foot walk and a patient-reported outcome measure
Farren B.S. Briggs, Douglas D. Gunzler, Deborah Miller, Daniel Ontaneda, Alessandro S. De Nadai
Mult Scler. Author manuscript; available in PMC 2024 Oct 25.
Published in final edited form as: Mult Scler. 2024 Oct; 30(11-12): 1479–1489. Published online 2024 Sep 5. doi: 10.1177/13524585241274607
PMCID:
PMC11502245
ArticlePDF–965K
15.
Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis
Karlo Toljan, Lynn Daboul, Praneeta Raza, Melissa L. Martin, Quy Cao, Carly M. O’Donnell, Paulo Rodrigues, John Derbyshire, Christina J. Azevedo, Amit Bar-Or, Eduardo Caverzasi, Peter A. Calabresi, Bruce A.C. Cree, Leorah Freeman, Roland G. Henry, Erin E Longbrake, Jiwon Oh, Nico Papinutto, Daniel Pelletier, Rohini D. Samudralwar, Matthew K. Schindler, Elias S. Sotirchos, Nancy L. Sicotte, Andrew J. Solomon, Russell T. Shinohara, Daniel S. Reich, Pascal Sati, Daniel Ontaneda
Mult Scler. Author manuscript; available in PMC 2024 Sep 25.
Published in final edited form as: Mult Scler. 2024 Sep; 30(10): 1268–1277. Published online 2024 Sep 5. doi: 10.1177/13524585241271988
PMCID:
PMC11421977
ArticlePDF–362K
16.
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder
Giovanni Novi, Elvira Sbragia, Luana Benedetti, Angelo Schenone, Antonio Uccelli, Roberta Magliozzi, Massimo Del Sette, Matilde Inglese, Alice Laroni
Mult Scler. 2024 Nov; 30(13): 1692–1696. Published online 2024 Jul 30. doi: 10.1177/13524585241261549
PMCID:
PMC11568681
ArticlePDF–1.5M
17.
From discovery to replication: Power and definitions matter for multiple sclerosis severity
Pernilla Stridh, Jesse Huang, Ingrid Kockum
Mult Scler. 2024 Sep; 30(10): 1385–1386. Published online 2024 Jul 26. doi: 10.1177/13524585241265021
PMCID:
PMC11440780
ArticlePDF–551K
18.
All women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated: Commentary
Kate Petheram, Ruth Dobson
Mult Scler. 2024 Aug; 30(9): 1111–1112. Published online 2024 Jun 22. doi: 10.1177/13524585241254989
PMCID:
PMC11363460
ArticlePDF–536K
19.
Monitoring cognitive functioning in multiple sclerosis will trigger anxiety in patients: Commentary
Sarah A Morrow, Laura Hancock
Mult Scler. 2024 Sep; 30(10): 1256–1257. Published online 2024 Jun 16. doi: 10.1177/13524585241261200
PMCID:
PMC11437696
ArticlePDF–554K
20.
Trends in central nervous system-active polypharmacy among people with multiple sclerosis
Hayden Naizer, Joseph Wozny, Trudy Millard Krause, Ethan Huson, Leorah Freeman
Mult Scler. 2024 Aug; 30(9): 1139–1150. Published online 2024 May 15. doi: 10.1177/13524585241251986
PMCID:
PMC11363472
ArticlePDF–1.1M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center